Iceni Seedcorn Fund Llp investment portfolio

Iceni Glycoscience develops rapid point‑of‑care diagnostic tests that use bespoke carbohydrate molecules to capture viruses and bacteria, creating devices for detecting infections such as equine influenza, norovirus and COVID‑19 for use by clinical laboratories, the NHS and other health providers. The company also provides a glycoscience platform that exploits glycans for broader diagnostic and therapeutic applications.

Inspiralis manufactures and supplies DNA‑modifying enzymes—including topoisomerases, helicases and ligases—along with assay kits, substrates and related reagents. It also offers contract research services such as compound screening, mechanism‑of‑action studies and mutant cloning to academic research institutes, pharmaceutical companies and biotech firms developing anti‑infective and anti‑cancer therapeutics.